Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
Janku F, Park H, Call SG, Madwani K, Oki Y, Subbiah V, Hong DS, Naing A, Velez-Bravo VM, Barnes TG, Hagemeister FB, Falchook GS, Karp DD, Wheler JJ, Piha-Paul SA, Garrido-Laguna I, Shpall EJ, Fayad LE, Neelapu SS, Meric-Bernstam F, Kurzrock R, Fanale MA. Janku F, et al. Among authors: velez bravo vm. Clin Cancer Res. 2020 Nov 1;26(21):5579-5587. doi: 10.1158/1078-0432.CCR-20-1215. Epub 2020 Oct 14. Clin Cancer Res. 2020. PMID: 33055173 Clinical Trial.
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy.
Park H, Garrido-Laguna I, Naing A, Fu S, Falchook GS, Piha-Paul SA, Wheler JJ, Hong DS, Tsimberidou AM, Subbiah V, Zinner RG, Kaseb AO, Patel S, Fanale MA, Velez-Bravo VM, Meric-Bernstam F, Kurzrock R, Janku F. Park H, et al. Among authors: velez bravo vm. Oncotarget. 2016 Oct 11;7(41):67521-67531. doi: 10.18632/oncotarget.11750. Oncotarget. 2016. PMID: 27589687 Free PMC article. Clinical Trial.
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
Gonzalez-Angulo AM, Krop I, Akcakanat A, Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S, Moulder-Thompson S, Velez-Bravo V, Sahin AA, Doyle LA, Do KA, Winer EP, Mills GB, Kurzrock R, Meric-Bernstam F. Gonzalez-Angulo AM, et al. J Natl Cancer Inst. 2015 Feb 16;107(3):dju493. doi: 10.1093/jnci/dju493. Print 2015 Mar. J Natl Cancer Inst. 2015. PMID: 25688104 Free PMC article. Clinical Trial.
Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced Malignancies.
Haraldsdottir S, Janku F, Poi M, Timmers C, Geyer S, Schaaf LJ, Sexton J, Wei L, Thurmond J, Velez-Bravo V, Stepanek VM, Bertino EM, Kendra K, Mortazavi A, Subbiah V, Phelps M, Shah MH. Haraldsdottir S, et al. JCO Precis Oncol. 2018 Nov;2:1-19. doi: 10.1200/PO.17.00247. JCO Precis Oncol. 2018. PMID: 35135123
Epidemiology of myelodysplastic syndromes.
Strom SS, Vélez-Bravo V, Estey EH. Strom SS, et al. Semin Hematol. 2008 Jan;45(1):8-13. doi: 10.1053/j.seminhematol.2007.10.003. Semin Hematol. 2008. PMID: 18179964 Review.